Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis

NCT02148744 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis
Allergic Conjunctivitis
Atopic Dermatitis

Interventions

BIOLOGICAL: XmAb7195
BIOLOGICAL: Placebo

Sponsor

Xencor, Inc.